1 / 5

Acute mountain sickness in athletes with neurological impairments

Acute mountain sickness in athletes with neurological impairments. Deepan C. Kamaraj, MD; Brad E. Dicianno, MD; Rory A. Cooper, PhD; John Hunter, MD; Jennifer L. Tang. Aim

genero
Download Presentation

Acute mountain sickness in athletes with neurological impairments

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Acute mountain sickness in athletes with neurological impairments Deepan C. Kamaraj, MD; Brad E. Dicianno, MD; Rory A. Cooper, PhD; John Hunter, MD; Jennifer L. Tang

  2. Aim • Compare occurrence of acute mountain sickness (AMS) in athletes with neurological impairments to physically active and physically inactive control subjects at high altitude. • Compare occurrence of AMS in athletes based on their disabilities. • Relevance • AMS in individuals with neurological impairments has not been considered in detail.

  3. Method • 168 subjects at National Veterans Winter Sports Clinic in Snowmass, CO, 2007-2009. • Athletes with disabilities. • Physically active controls: trainers, volunteers, or individuals with visual impairments participating in sports activities. • Physically inactive controls: trainers, volunteers, or individuals with visual impairments not participating in sports activities. • Lake Louise Score used to quantify AMS symptoms.

  4. Results • Higher than anticipated occurrence of AMS (42.85%) among study population. • Significantly high Lake Louis Scores among athletes with neurological impairments. • Disability group, prior history of AMS, and prior occurrence of headache at high altitude predicted development of AMS symptoms.

  5. Conclusion • More research is warranted specifically targeting interaction between factors affecting AMS and pathophysiology of neurological impairments. • Will further our understanding of prophylactic medications and treatments for AMS. • Especially important because many military personnel with neurological impairments continue on Active Duty.

More Related